The combined company will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.
Read full story
Research news
Wednesday, October 30, 2024 New study shows combination therapy slows cognitive decline in at-risk populations
A new study has demonstrated that a combination therapy can slow cognitive decline in older adults at risk for dementia.
Read full story
A new study has demonstrated that a combination therapy can slow cognitive decline in older adults at risk for dementia.
Read full story
Thursday, October 17, 2024 SRI spin-off company, Conavi Medical, completes reverse takeover to become public
The combined company will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.
Read full story
The combined company will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.
Read full story
Tuesday, October 15, 2024 Osteoporosis care gap: researchers find majority of patients not receiving recommended preventative treatment
A new study has found that two thirds of seniors who suffer an osteoporotic fracture of the hip, pelvis, or spine in Ontario are not getting medications that they need to prevent future fractures.
Read full story
A new study has found that two thirds of seniors who suffer an osteoporotic fracture of the hip, pelvis, or spine in Ontario are not getting medications that they need to prevent future fractures.
Read full story
Tuesday, October 15, 2024 Non-invasive brain surgery safe and effective in treating OCD and depression
A non-invasive surgery focusing ultrasound waves deep into the brain has been shown to be a safe and effective treatment for OCD, as well as major depressive disorder MDD.
Read full story
A non-invasive surgery focusing ultrasound waves deep into the brain has been shown to be a safe and effective treatment for OCD, as well as major depressive disorder MDD.
Read full story
Monday, October 7, 2024 SRI spin-off company, Arrayus, announces Health Canada approval of its focused ultrasound therapy system
Arrayus Technologies Inc., a SRI spin-off company, is pleased to announce that its MRI-guided FUS system has been granted approval by Health Canada for the ablation of uterine fibroid tissue.
Read full story
Arrayus Technologies Inc., a SRI spin-off company, is pleased to announce that its MRI-guided FUS system has been granted approval by Health Canada for the ablation of uterine fibroid tissue.
Read full story
